Molecular Insight Pharmaceuticals, Inc. Says Gets Going Concern Warning from Auditors

Reuters -- Molecular Insight Pharmaceuticals Inc posted a narrower-than-expected quarterly loss, but said its auditors have expressed doubts on its ability to continue as a going concern, partly due to recurring losses from its operations.